Black Diamond Therapeutics
BDTX
BDTX
87 hedge funds and large institutions have $103M invested in Black Diamond Therapeutics in 2024 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 35 increasing their positions, 16 reducing their positions, and 28 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
87
Holders Change
-9
Holders Change %
-9.38%
% of All Funds
1.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
35
Reduced
16
Closed
28
Calls
$38K
Puts
$165K
Net Calls
-$127K
Net Calls Change
+$2.44M
Top Buyers
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$1.5M |
| 2 |
Renaissance Technologies
New York
|
+$1.39M |
| 3 |
VPC
Vestal Point Capital
New York
|
+$1.22M |
| 4 |
AAA
Affinity Asset Advisors
New York
|
+$1.2M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$868K |
Top Sellers
| 1 |
ECM
ExodusPoint Capital Management
New York
|
-$3.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.06M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$3.03M |
| 4 |
OCA
Octagon Capital Advisors
New York
|
-$2.58M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
-$2.41M |
